Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| RDDT | Wong Jennifer L. | Chief Operating Officer | 14.10.2026 | Verkauf | 152,14 | 5.495 | 836.009 | Form 4 |
| RDDT | Wong Jennifer L. | Chief Operating Officer | 14.10.2026 | Verkauf | 150,87 | 11.200 | 1.689.744 | Form 4 |
| RDDT | Wong Jennifer L. | Chief Operating Officer | 14.10.2026 | Verkauf | 150,08 | 6.399 | 960.362 | Form 4 |
| RDDT | Wong Jennifer L. | Chief Operating Officer | 14.10.2026 | Verkauf | 148,86 | 26.105 | 3.885.990 | Form 4 |
| RDDT | Wong Jennifer L. | Chief Operating Officer | 14.10.2026 | Optionsausübung | 25,29 | 14.563 | 368.298 | Form 4 |
| RDDT | Wong Jennifer L. | Chief Operating Officer | 14.10.2026 | Optionsausübung | 20,76 | 45.437 | 943.272 | Form 4 |
| RAL | Newcombe Tamara S. | President and CEO | 14.10.2026 | Verkauf | 70,58 | 12.936 | 913.023 | Form 4 |
| RAL | Newcombe Tamara S. | President and CEO | 14.10.2026 | Optionsausübung | 31,86 | 3.303 | 105.234 | Form 4 |
| RAL | Newcombe Tamara S. | President and CEO | 14.10.2026 | Optionsausübung | 31,86 | 9.633 | 306.907 | Form 4 |
| RRX | Paul Aamir | Chief Executive Officer | 14.10.2026 | Zuteilung | 157,06 | 108 | 16.962 | Form 4 |
| RRX | Klossner Mark | EVP and Pres. IPS* | 14.10.2026 | Zuteilung | 157,06 | 12 | 1.885 | Form 4 |
| RRX | Long Kevin | EVP and President, AMC* | 14.10.2026 | Zuteilung | 157,06 | 13 | 2.042 | Form 4 |
| RRX | Hodge Rashida A | Director | 14.10.2026 | Zuteilung | 157,06 | 2 | 314 | Form 4 |
| RRX | Dubovoy Hugo Jr. | EVP, General Counsel & Sec.* | 14.10.2026 | Zuteilung | 157,06 | 13 | 2.042 | Form 4 |
| RRX | Dickson Timothy A. | SVP & Chief Digi & Info Ofc* | 14.10.2026 | Zuteilung | 157,06 | 4 | 628 | Form 4 |
| RRX | Lang Brooke | EVP and President, PES* | 14.10.2026 | Zuteilung | 157,06 | 10 | 1.571 | Form 4 |
| RRX | Scarpelli Alexander P | SVP, Corp. Controller and CAO* | 14.10.2026 | Zuteilung | 157,06 | 3 | 471 | Form 4 |
| RRX | Lewis Cheryl | EVP and Chief HR Officer* | 14.10.2026 | Zuteilung | 157,06 | 12 | 1.885 | Form 4 |
| RRX | Morton Jerrald R | Executive Vice President | 14.10.2026 | Zuteilung | 157,06 | 17 | 2.670 | Form 4 |
| RRX | Rehard Robert | EVP and CFO* | 14.10.2026 | Zuteilung | 157,06 | 23 | 3.612 | Form 4 |
| RRX | Bakker Gerben | Director | 14.10.2026 | Zuteilung | 157,06 | 2 | 314 | Form 4 |
| RRX | Burt Stephen M | Director | 14.10.2026 | Zuteilung | 157,06 | 2 | 314 | Form 4 |
| RRX | Walker-Lee Robin A | Director | 14.10.2026 | Zuteilung | 157,06 | 2 | 314 | Form 4 |
| RRX | Bertsch Jan | Director | 14.10.2026 | Zuteilung | 157,06 | 2 | 314 | Form 4 |
| RRX | Hilton Michael F | Director | 14.10.2026 | Zuteilung | 157,06 | 4 | 628 | Form 4 |
| RRX | Doss Michael P | Director | 14.10.2026 | Zuteilung | 157,06 | 4 | 628 | Form 4 |
| RRX | Crandall Theodore D | Director | 14.10.2026 | Zuteilung | 157,06 | 2 | 314 | Form 4 |
| RRX | Sachdev Rakesh | Director | 14.10.2026 | Zuteilung | 157,06 | 2 | 314 | Form 4 |
| RRX | Stoelting Curtis W | Director | 14.10.2026 | Zuteilung | 157,06 | 2 | 314 | Form 4 |
| RPAY | Dempsey Tyler B | General Counsel | 14.10.2026 | Verkauf | 4,00 | 4.886 | 19.544 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 781,47 | 50 | 39.074 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 780,63 | 463 | 361.432 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 779,59 | 380 | 296.244 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 778,64 | 454 | 353.503 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 777,76 | 38 | 29.555 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 776,31 | 66 | 51.236 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 775,46 | 376 | 291.573 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 774,48 | 121 | 93.712 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 773,40 | 224 | 173.242 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 772,56 | 211 | 163.010 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 771,56 | 283 | 218.351 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 770,20 | 12 | 9.242 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 769,30 | 127 | 97.701 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 768,33 | 105 | 80.675 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 767,39 | 192 | 147.339 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 766,47 | 279 | 213.845 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 765,39 | 271 | 207.421 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 764,40 | 219 | 167.404 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 763,76 | 25 | 19.094 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 762,57 | 55 | 41.941 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 761,36 | 27 | 20.557 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 760,65 | 74 | 56.288 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 759,96 | 14 | 10.639 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 758,16 | 24 | 18.196 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 757,68 | 16 | 12.123 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 755,91 | 35 | 26.457 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 753,76 | 6 | 4.523 | Form 4 |
| RPAY | Dempsey Tyler B | General Counsel | 13.10.2026 | Verkauf | 4,00 | 8.392 | 33.568 | Form 4 |
| RDDT | Huffman Steve Ladd | CEO & President | 13.10.2026 | Verkauf | 163,72 | 500 | 81.860 | Form 4 |
| RDDT | Huffman Steve Ladd | CEO & President | 13.10.2026 | Verkauf | 162,80 | 700 | 113.960 | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).